AMBRA1 attenuates the proliferation of uveal melanoma cells
暂无分享,去创建一个
[1] Wenli Lu,et al. Characterization of Two Loss-of-Function NF1 Variants in Chinese Patients and Potential Molecular Interpretations of Phenotypes , 2021, Frontiers in Genetics.
[2] Colin J. Daniel,et al. Loss of Ambra1 promotes melanoma growth and invasion , 2021, Nature Communications.
[3] D. Petrov,et al. The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D , 2021, Nature.
[4] Colin J. Daniel,et al. AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity , 2021, Nature.
[5] M. Pagano,et al. CRL4AMBRA1 is a master regulator of D-type cyclins , 2021, Nature.
[6] Xiaoxu Tian,et al. MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty , 2021, Nucleic acids research.
[7] Xianqun Fan,et al. Uveal melanoma: progress in molecular biology and therapeutics , 2020, Therapeutic advances in medical oncology.
[8] M. Kimura,et al. AMBRA1 controls antigen-driven activation and proliferation of naïve T cells. , 2020, International immunology.
[9] Chao Peng,et al. An Integrative Synthetic Biology Approach to Interrogating Cellular Ubiquitin and Ufm Signaling , 2020, International journal of molecular sciences.
[10] G. Schwartz,et al. Metastatic disease from uveal melanoma: treatment options and future prospects , 2016, British Journal of Ophthalmology.
[11] David Komander,et al. Ubiquitin modifications , 2016, Cell Research.
[12] J. Morrow,et al. Targeting ubiquitination for cancer therapies. , 2015, Future medicinal chemistry.
[13] Ivan Dikic,et al. Ubiquitination in disease pathogenesis and treatment , 2014, Nature Medicine.
[14] T. Aytekin,et al. A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[15] H. Ji,et al. Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression. , 2014, Cancer cell.
[16] S. Ge,et al. Detection and Validation of Circulating Endothelial Cells, a Blood-based Diagnostic Marker of Acute Myocardial Infarction , 2013, PloS one.
[17] Sanket U. Shah,et al. Iris melanoma: features and prognosis in 317 children and adults. , 2012, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[18] J. O'Brien,et al. Mutations in GNA11 in uveal melanoma. , 2010, The New England journal of medicine.
[19] Wen-li Ma,et al. FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma. , 2010, Oncology reports.
[20] M. Barbacid,et al. Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.
[21] P. Sorensen,et al. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers , 2007, Nature Medicine.
[22] N. Laperriere,et al. Management of single brain metastasis: a practice guideline , 2007, Current oncology.
[23] J. Alao,et al. Molecular Cancer BioMed Central Review The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention , 2007 .
[24] A. Klein-Szanto,et al. Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex , 2006 .
[25] A. Klein-Szanto,et al. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. , 2006, Molecular cell.
[26] D. Germain,et al. A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT , 2001, Oncogene.
[27] S. Legha,et al. Uveal melanoma: natural history and treatment options for metastatic disease. , 1999, Melanoma research.